mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

被引：544

作者：

Goel, Rishi R. ^{[1
,2
]}

Painter, Mark M. ^{[1
,2
]}

Apostolidis, Sokratis A. ^{[1
,2
,3
]}

Mathew, Divij ^{[1
,2
]}

Meng, Wenzhao ^{[1
,4
]}

Rosenfeld, Aaron M. ^{[1
,4
]}

Lundgreen, Kendall A. ^{[5
]}

Reynaldi, Arnold ^{[6
]}

Khoury, David S. ^{[6
]}

Pattekar, Ajinkya ^{[2
]}

Gouma, Sigrid ^{[5
]}

Kuri-Cervantes, Leticia ^{[1
,5
]}

Hicks, Philip ^{[5
]}

Dysinger, Sarah ^{[5
]}

Hicks, Amanda ^{[2
]}

Sharma, Harsh ^{[2
]}

Herring, Sarah ^{[2
]}

Korte, Scott ^{[2
]}

Baxter, Amy E. ^{[1
]}

Oldridge, Derek A. ^{[1
,4
]}

Giles, Josephine R. ^{[1
,7
,8
]}

Weirick, Madison E. ^{[5
]}

McAllister, Christopher M. ^{[5
]}

Awofolaju, Moses ^{[5
]}

Tanenbaum, Nicole ^{[5
]}

Drapeau, Elizabeth M. ^{[5
]}

Dougherty, Jeanette ^{[1
]}

Long, Sherea ^{[1
]}

D'Andrea, Kurt ^{[1
]}

Hamilton, Jacob T. ^{[2
,5
]}

McLaughlin, Maura ^{[1
]}

Williams, Justine C. ^{[2
]}

Adamski, Sharon ^{[2
]}

Kuthuru, Oliva ^{[1
]}

Frank, Ian ^{[9
]}

Betts, Michael R. ^{[1
,5
]}

Vella, Laura A. ^{[10
]}

Grifoni, Alba ^{[11
]}

Weiskopf, Daniela ^{[11
]}

Sette, Alessandro ^{[11
,12
]}

Hensley, Scott E. ^{[5
]}

Davenport, Miles P. ^{[6
]}

Bates, Paul ^{[5
]}

Prak, Eline T. Luning ^{[1
,4
]}

Greenplate, Allison R. ^{[1
,2
]}

Wherry, E. John ^{[1
,2
,7
,8
]}

机构：

[1] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA

[2] Univ Penn, Immune Hlth, Perelman Sch Med, Philadelphia, PA 19104 USA

[3] Univ Penn, Div Rheumatol, Perelman Sch Med, Philadelphia, PA 19104 USA

[4] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA

[5] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA

[6] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia

[7] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA

[8] Univ Penn, Parker Inst Canc Immunotherapy, Perelman Sch Med, Philadelphia, PA 19104 USA

[9] Univ Penn, Div Infect Dis, Perelman Sch Med, Philadelphia, PA 19104 USA

[10] Childrens Hosp Philadelphia, Dept Pediat, Div Infect Dis, Philadelphia, PA 19104 USA

[11] La Jolla Inst Immunol LJI, Ctr Infect Dis & Vaccine Res, La Jolla, CA USA

[12] Univ Calif San Diego UCSD, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA USA

来源：

SCIENCE | 2021年 / 374卷 / 6572期

基金：

英国医学研究理事会; 澳大利亚研究理事会; 澳大利亚国家健康与医学研究理事会;

关键词：

CELL; EXPLORATION; INFECTION; SYSTEM;

D O I：

10.1126/science.abm0829

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The durability of immune memory after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccination remains unclear. In this study, we longitudinally profiled vaccine responses in SARS-CoV-2-naive and -recovered individuals for 6 months after vaccination. Antibodies declined from peak levels but remained detectable in most subjects at 6 months. By contrast, mRNA vaccines generated functional memory B cells that increased from 3 to 6 months postvaccination, with the majority of these cells cross-binding the Alpha, Beta, and Delta variants. mRNA vaccination further induced antigen-specific CD4(+) and CD8(+) T cells, and early CD4(+) T cell responses correlated with long-term humoral immunity. Recall responses to vaccination in individuals with preexisting immunity primarily increased antibody levels without substantially altering antibody decay rates. Together, these findings demonstrate robust cellular immune memory to SARS-CoV-2 and its variants for at least 6 months after mRNA vaccination.

引用

下载

页码：1214 / +

页数：41

共 50 条

[41] SARS-CoV-2 variants of concern: the knowns and unknowns
Lessells, Richard J.
ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2021, 40 (03)
[42] The Emerging Concern and Interest SARS-CoV-2 Variants
Janik, Edyta
Niemcewicz, Marcin
Podogrocki, Marcin
Majsterek, Ireneusz
Bijak, Michal
PATHOGENS, 2021, 10 (06):
[43] SARS-CoV-2 variants of concern are emerging in India
Singh, Jasdeep
Rahman, Syed Asad
Ehtesham, Nasreen Z.
Hira, Subhash
Hasnain, Seyed E.
NATURE MEDICINE, 2021, 27 (07) : 1131 - 1133
[44] Immune Response to SARS-CoV-2 Vaccines
Bellamkonda, Navya
Lambe, Upendra Pradeep
Sawant, Sonali
Nandi, Shyam Sundar
Chakraborty, Chiranjib
Shukla, Deepak
BIOMEDICINES, 2022, 10 (07)
[45] A comparison of transmissibility of SARS-CoV-2 variants of concern
S. S. Manathunga
I. A. Abeyagunawardena
S. D. Dharmaratne
Virology Journal, 20
[46] A comparison of transmissibility of SARS-CoV-2 variants of concern
Manathunga, S. S.
Abeyagunawardena, I. A.
Dharmaratne, S. D.
VIROLOGY JOURNAL, 2023, 20 (01)
[47] SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines
Li, Xi
Mi, Ze
Liu, Zhenguo
Rong, Pengfei
FRONTIERS IN MICROBIOLOGY, 2024, 15
[48] Developing pan-β-coronavirus vaccines against emerging SARS-CoV-2 variants of concern
Su, Shan
Li, Weihua
Jiang, Shibo
TRENDS IN IMMUNOLOGY, 2022, 43 (03) : 170 - 172
[49] SARS-CoV-2 variants in relation to screening and vaccines
Rouzioux, C.
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2022, 206 (02): : 215 - 218
[50] SARS-CoV-2 Variants, Vaccines, and Host Immunity
Mistry, Priyal
Barmania, Fatima
Mellet, Juanita
Peta, Kimberly
Strydom, Adele
Viljoen, Ignatius M.
James, William
Gordon, Siamon
Pepper, Michael S.
FRONTIERS IN IMMUNOLOGY, 2022, 12

← 1 2 3 4 5 →